Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Codexis Inc. (CDXS)

12.95   -0.56 (-4.15%) 02-25 16:00
Open: 13.55 Pre. Close: 13.51
High: 13.59 Low: 12.89
Volume: 313,306 Market Cap: 758M
Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.605 - 13.716 13.716 - 13.79
Low: 12.667 - 12.785 12.785 - 12.865
Close: 12.795 - 12.978 12.978 - 13.102

Technical analysis

as of: 2020-02-25 4:28:04 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 18.74     One year: 21.02
Support: Support1: 12.89    Support2: 10.72
Resistance: Resistance1: 16.05    Resistance2: 18.00
Pivot: 14.66
Moving Average: MA(5): 13.70     MA(20): 15.01
MA(100): 15.31     MA(250): 16.86
MACD: MACD(12,26): -0.85     Signal(9): -0.67
Stochastic oscillator: %K(14,3): 6.39     %D(3): 7.06
RSI: RSI(14): 19.50
52-week: High: 22.38  Low: 12.68  Change(%): -40.4
Average Vol(K): 3-Month: 33948  10-Days: 45603

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CDXS has closed above bottom band by 10.1%. Bollinger Bands are 100.5% wider than normal. The large width of the bands suggest high volatility as compared to CDXS's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.

Headline News

Codexis, Inc. (NASDAQ:CDXS) Expected to Post Quarterly Sales of $22.82 Million
Equities analysts forecast that Codexis, Inc. (NASDAQ:CDXS) will post $22.82 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Codexis’ earnings, with estimates ranging from $20.70 million to $24.93 million. Codexis posted sales of $16.07 million during the same quarter last year, which would indicate a […]

Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
Codexis (CDXS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 58.52
Shares Float (M) 42.63
% Held by Insiders 3.66
% Held by Institutions 88.86
Shares Short (K) 4990
Shares Short P. Month (K)

Stock Financials

EPS -0.210
Book Value (p.s.) 1.760
PEG Ratio -4.69
Profit Margin -17.85
Operating Margin -18.59
Return on Assets (ttm) -6.8
Return on Equity (ttm) -15.0
Qtrly Rev. Growth 29.3
Gross Profit (p.s.) 0.308
Sales Per Share
EBITDA (p.s.) -0.182
Qtrly Earnings Growth
Operating Cash Flow (M) -9.62
Levered Free Cash Flow (M) -7.80

Stock Valuations

P/E -61.67
P/E Growth Ratio -0.04
P/BV 7.36
P/S 10.88
P/CF -78.78

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.